20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TICAGRELOR, with a corresponding US DMF Number 31482.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 03, 2019, and payment made on March 27, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II